Coronary Artery Disease Clinical Trials in Buffalo, New York

5 studies are recruiting for coronary artery disease in Buffalo, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

   The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   University of Buffalo (Buffalo General), Buffalo, New York

   Locations

   19 in total

   Run by

   Supira Medical

   See if you can join NCT07296744 on ClinicalTrials.gov

2. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

   Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

   Stage

   Not phased

   Ages

   Any age

   Site

   Trinity Medical WNY, Buffalo, New York

   Locations

   48 in total

   Run by

   Minneapolis Heart Institute Foundation

   See if you can join NCT02061436 on ClinicalTrials.gov

3. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kaleida Health, Buffalo, New York

   Locations

   51 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

4. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

   Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   VA Western New York Healthcare System, Buffalo, NY, Buffalo, New York

   Locations

   9 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05618353 on ClinicalTrials.gov

5. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   University at Buffalo, Buffalo, New York

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov